KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Edwards Lifesciences (EW) Short term Debt (2017 - 2018)

Historic Short term Debt for Edwards Lifesciences (EW) over the last 7 years, with Q3 2018 value amounting to $599.9 million.

  • Edwards Lifesciences' Short term Debt rose 134554.22% to $599.9 million in Q3 2018 from the same period last year, while for Sep 2018 it was $599.9 million, marking a year-over-year increase of 134554.22%. This contributed to the annual value of $598.0 million for FY2017, which is N/A changed from last year.
  • As of Q3 2018, Edwards Lifesciences' Short term Debt stood at $599.9 million, which was up 134554.22% from $599.2 million recorded in Q2 2018.
  • Over the past 5 years, Edwards Lifesciences' Short term Debt peaked at $599.9 million during Q3 2018, and registered a low of $2.2 million during Q3 2014.
  • Moreover, its 3-year median value for Short term Debt was $598.0 million (2017), whereas its average is $348.9 million.
  • Per our database at Business Quant, Edwards Lifesciences' Short term Debt plummeted by 8015.27% in 2014 and then soared by 134554.22% in 2018.
  • Quarter analysis of 3 years shows Edwards Lifesciences' Short term Debt stood at $2.6 million in 2014, then skyrocketed by 22900.0% to $598.0 million in 2017, then rose by 0.32% to $599.9 million in 2018.
  • Its last three reported values are $599.9 million in Q3 2018, $599.2 million for Q2 2018, and $598.6 million during Q1 2018.